The beta-3 adrenergic agonist (CL-316,243)restores the expression of down-regulated fattyacid oxidation genes in type 2 diabetic miceβ-3肾上腺素能激动剂(CL—316243) 下调下调脂肪的表达 2型糖尿病小鼠的酸氧化基因

The beta-3 adrenergic agonist (CL-316,243)restores the expression of down-regulated fattyacid oxidation genes in type 2 diabetic miceβ-3肾上腺素能激动剂(CL—316243) 下调下调脂肪的表达 2型糖尿病小鼠的酸氧化基因

ID:40850213

大小:1.42 MB

页数:14页

时间:2019-08-08

The beta-3 adrenergic agonist (CL-316,243)restores the expression of down-regulated fattyacid oxidation genes in type 2 diabetic miceβ-3肾上腺素能激动剂(CL—316243) 下调下调脂肪的表达 2型糖尿病小鼠的酸氧化基因_第1页
The beta-3 adrenergic agonist (CL-316,243)restores the expression of down-regulated fattyacid oxidation genes in type 2 diabetic miceβ-3肾上腺素能激动剂(CL—316243) 下调下调脂肪的表达 2型糖尿病小鼠的酸氧化基因_第2页
The beta-3 adrenergic agonist (CL-316,243)restores the expression of down-regulated fattyacid oxidation genes in type 2 diabetic miceβ-3肾上腺素能激动剂(CL—316243) 下调下调脂肪的表达 2型糖尿病小鼠的酸氧化基因_第3页
The beta-3 adrenergic agonist (CL-316,243)restores the expression of down-regulated fattyacid oxidation genes in type 2 diabetic miceβ-3肾上腺素能激动剂(CL—316243) 下调下调脂肪的表达 2型糖尿病小鼠的酸氧化基因_第4页
The beta-3 adrenergic agonist (CL-316,243)restores the expression of down-regulated fattyacid oxidation genes in type 2 diabetic miceβ-3肾上腺素能激动剂(CL—316243) 下调下调脂肪的表达 2型糖尿病小鼠的酸氧化基因_第5页
资源描述:

《The beta-3 adrenergic agonist (CL-316,243)restores the expression of down-regulated fattyacid oxidation genes in type 2 diabetic miceβ-3肾上腺素能激动剂(CL—316243) 下调下调脂肪的表达 2型糖尿病小鼠的酸氧化基因》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库

1、Kumaretal.Nutrition&Metabolism(2015)12:8DOI10.1186/s12986-015-0003-8RESEARCHOpenAccessThebeta-3adrenergicagonist(CL-316,243)restorestheexpressionofdown-regulatedfattyacidoxidationgenesintype2diabeticmice1,2123*AmitKumar,JosephShiloach,MichaelJBetenbaughandEmilyJGa

2、llagherAbstractBackground:ThehallmarkofType2diabetes(T2D)ishyperglycemia,althoughtherearemultipleothermetabolicabnormalitiesthatoccurwithT2D,includinginsulinresistanceanddyslipidemia.ToadvanceT2Dpreventionanddeveloptargetedtherapiesforitstreatment,agreaterundersta

3、ndingofthealterationsinmetabolictissuesassociatedwithT2Disnecessary.Theaimofthisstudywastousemicroarrayanalysisofgeneexpressioninmetabolictissuesfromamousemodelofpre-diabetesandT2DtofurtherunderstandthemetabolicabnormalitiesthatmaycontributetoT2D.Wealsoaimedtounco

4、verthenovelgenesandpathwaysregulatedbytheinsulinsensitizingagent(CL-316,243)toidentifykeypathwaysandtargetgenesinmetabolictissuesthatcanreversethediabeticphenotype.Methods:MaleMKRmiceonanFVB/nbackgroundandagematchedwild-type(WT)FVB/nmicewereusedinallexperiments.Sk

5、eletalmuscle,liverandfatwereisolatedfromprediabetic(3weekold)anddiabetic(8weekold)MKRmice.MaleMKRmiceweretreatedwithCL-316,243.Skeletalmuscle,liverandfatwereisolatedafterthetreatmentperiod.RNAwasisolatedfromthemetabolictissuesandsubjectedtomicroarrayandKEGGdatabas

6、eanalysis.Results:SignificantdecreasesintheexpressionofmitochondrialandperoxisomalfattyacidoxidationgeneswerefoundintheskeletalmuscleandadiposetissueofadultMKRmice,andtheliverofpre-diabeticMKRmice,comparedtoWTcontrols.AftertreatmentwithCL-316,243,thecirculatingglu

7、coseandinsulinconcentrationsintheMKRmiceimproved,anincreaseintheexpressionofperoxisomalfattyacidoxidationgeneswasobservedinadditiontoadecreaseintheexpressionofretinaldehydedehydrogenases.ThesegeneswerenotpreviouslyknowntoberegulatedbyCL-316,243treatment.Conclusion

8、s:ThisstudyuncoversnovelgenesthatmaycontributetopharmacologicalreversalofinsulinresistanceandT2Dandmaybetargetsfortreatment.Inaddition,itexplainsthelowe

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。